WASHINGTON, Nov 17: Pfizer asked U.S. regulators Tuesday to authorize its experimental pill for COVID-19, setting the stage for a likely launch this winter of a promising treatment that can be taken at home.
U.S., Nov 10: Pfizer asked U.S. regulators Tuesday to allow boosters of its COVID-19 vaccine for anyone 18 or older, a step that comes amid concern about increased spread of the coronavirus with holiday travel and gatherings.
1657795155_1200.jpeg)
1657799305_1200.jpeg)
1647395070_1200.jpeg)
